Commercialization of Pharma-Plant
Customized pharmaceutical equipment & facility
SMC has been involved in commercialization of pharma plant since its establishment. SMC, as an exclusive agent of leading Korean machinery manufacturers, has successfully combined equipment supply with advanced pharmaceutical technology of leading Korean pharmaceutical companies and created a new model of commercialization of overseas pharmaceutical plant.
This model is for fast-growing pharmerging countries and it benefits to buyers in saving the budget and shortening the R&D time.
The 1st project is being realized at JSC Chimpharm's site in Kazakhstan in cooperation with Polpharma Group and Korean consortium, DAIHAN Pharmaceutical Corporation and Fine F.A and will be completed by November, 2013.
Following projects are under development with Medpolymer, Kraspharma and Biosintez in Russia.
With SMC's project control and fully customized machinery and facility of top Korean machinery manufacturers, you will facilitate GMP standard manufacturing line and advanced, Korea-guaranteed manufacturing technology